Question Bank › Relationships widening on the customers' initiat

Relationships widening on the customers' initiative, with the numbers still catching up

Calls Tested
449
Answered YES
5
Hit Rate
1.1%
rare by design

COMPASS Pathways plc (CMPS) — this company's answers

NO on the Q3 2023 call 2023-11-04 F
The model's full reasoning — Q3 2023 call → NOWe need to determine if the transcript describes multiple existing relationships that have recently gotten bigger, and that the reported results reflect only early part of these widenings. Let's analyze. The question asks: "On this call, does management describe that SEVERAL of the company's EXISTING commercial relationships have RECENTLY GOTTEN BIGGER — counterparties the company had already won (customers, accounts, partners, distributors, members, or programs) that have, in the recent period, chosen to take a wider or deeper commitment than they had before — AND does management convey that the reported results reflect only the early part of these widenings, with most of their contribution still ahead?" We need to look for evidence of existing relationships widening. The transcript discusses clinical trials, site initiations, and the growth of esketamine (Spravato) sales. But that's not about COMPASS's own commercial relationships. COMPASS is a biotech company with no approved product yet. They are running clinical trials. The "commercial relationships" might refer to clinical trial sites? Or partnerships? The question is about "existing commercial relationships" that have "gotten bigger" - counterparties like customers, accounts, partners, distributors, members, or programs. In the context of a biotech with no product, they might have partnerships with other companies? Or they might have clinical trial sites that are expanding? But the question specifically says "commercial relationships" and "counterparties the company had already won" - meaning existing customers or partners. The transcript does not mention any such relationships. It talks about site initiations for clinical trials, but that's not commercial. It talks about the growth of esketamine sales (Spravato) which is a competitor or complementary product, but that's not COMPASS's own relationship. It talks about the CPT code for psychedelic medications, but that's not a relationship. The only possible "existing relationships" might be the clinical trial sites that are being initiated. But those are not commercial relationships; they are clinical trial sites. The question is about "commercial relationships" - likely meaning customers, partners, etc. The transcript does not describe any existing customers or partners expanding their commitments. The company is pre-commercial.

← Back to the full CMPS analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management describe that SEVERAL of the company's EXISTING commercial relationships have RECENTLY GOTTEN BIGGER — counterparties the company had already won (customers, accounts, partners, distributors, members, or programs) that have, in the recent period, chosen to take a wider or deeper commitment than they had before — AND does management convey that the reported results reflect only the early part of these widenings, with most of their contribution still ahead? Answer YES when management's own words convey BOTH halves of this one phenomenon, in whatever form fits the business: (1) MULTIPLE EXISTING RELATIONSHIPS HAVE RECENTLY WIDENED, BY THE COUNTERPARTY'S OWN CHOICE. Management recounts that more than one already-established counterparty has stepped up its commitment in the recent period — in whatever form fits the industry, such as: existing customers adding locations, sites, users, lines, units, or departments; accounts that started with one product or use now taking additional ones; partners or distributors extending the relationship into new territories, categories, or scope; early deployments being broadened by the same counterparty; repeat orders arriving meaningfully larger than the initial ones; or relationships moving from an initial phase into a bigger committed phase. The widenings must be described as real and recent — decisions the counterparties actually made, with the resulting business signed, ordered, begun, or already flowing — not hoped for, in negotiation, or merely a pipeline. The pattern should span more than one relationship rather than a single large deal, and the growth should come from the counterparties choosing to take more, not merely from price increases pushed onto the same volumes. (2) THE NUMBERS ARE STILL CATCHING UP, AND MANAGEMENT SAYS SO. Management conveys, directly or plainly in substance, that these widened commitments have contributed only partially to the results being reported — because the expansions began recently, are still ramping toward their intended level, or have most of their delivery, rollout, or volume scheduled ahead — so the just-reported numbers understate the level of business these relationships have already committed to. Management should treat this widening pattern as meaningful to where the company is heading, discussing it as part of the company's trajectory rather than as a passing detail. Answer NO if the growth discussed comes mainly from winning brand-new customers, new markets, or new logos rather than from existing relationships getting bigger. NO if only one relationship is described as widening, however large. NO if the widenings are only hoped for, proposed, in pilot with no commitment, or contingent on decisions not yet made. NO if the increase is chiefly price increases on unchanged volumes, ordinary reorders at the usual size, or routine fluctuations in order timing. NO if the widened business is already fully reflected in the reported results, with no meaningful contribution still ahead. NO if management attributes the step-ups mainly to a one-time event, catch-up, pull-forward, or temporary condition it expects to fade. NO if the pattern appears only in an analyst's question or model that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
DUOT Duos Technologies Group, Inc. Q4 2023 2024-04-01 F
ZVIA Zevia PBC Q1 2022 2022-05-12 B
ATI Allegheny Technologies Incorporated Q1 2018 2018-04-24 B
PTC PTC Inc. Q3 2017 2017-07-19 C+
GOGO Gogo Inc. Q1 2016 2016-05-06 C+

How the model reasoned

ATI · Q1 2018 → YESThe question is: Does management describe that SEVERAL of the company's EXISTING commercial relationships have RECENTLY GOTTEN BIGGER — counterparties the company had already won that have chosen to t...YES The transcript shows management describing multiple existing relationships (major engine OEM customers, Pratt & Whitney/UTC, Boeing, Airbus, and other aerospace/defense customers) that have recently widened commitments through production ramps, emergent demand above contractual share, and long-term agreements. It also conveys that these widenings are still ramping 2018 as an early phase of multi-year expansion, with most of the contribution ahead in 2019–2020.
GOGO · Q1 2016 → YESThe question is: Does management describe that SEVERAL of the company's EXISTING commercial relationships have RECENTLY GOTTEN BIGGER — counterparties the company had already won that have chosen to t...YES The transcript shows management describing multiple existing relationships that recently widened: Delta increased its commitment to more than 600 2Ku aircraft (bringing total awarded over 1,000), and Air Canada extended its relationship to the entire wide-body international fleet. These are presented as recent decisions by established counterparties.
ZVIA · Q1 2022 → YESThe question is: Does management describe that SEVERAL of the company's EXISTING commercial relationships have RECENTLY GOTTEN BIGGER — counterparties the company had already won that have chosen to t...

More from the question bank

Engine explained, runway namedDeliveries running ahead of the moneyInheritance being cashed inWhere the money wentRacing a clock somebody else setRepeat customers are now the ones asking forAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.